Evidence mapPaperPMID 41226688Full record

ArticleInternational journal of molecular sciences2025

Molecular Implications of

Mateusz Wichtowski, Agnieszka Kołacińska-Wow, Katarzyna Skrzypek, Ewa Jabłońska, Katarzyna Płoszka, Damian Kołat, Sylwia Paszek, Izabela Zawlik, Elżbieta Płuciennik, Natalia Potocka and 6 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mateusz WichtowskiDepartment of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland.
Agnieszka Kołacińska-WowDepartment of Oncological Physiotherapy, Medical University of Lodz, Paderewskiego 4, 93-509 Lodz, Poland.
Katarzyna SkrzypekDepartment of Translational Research, Nofer Institute of Occupational Medicine, St. Teresy 8 Street, 91-348 Lodz, Poland.ORCID 0000-0003-2940-0449
Ewa JabłońskaDepartment of Chemical Safety, Nofer Institute of Occupational Medicine, St. Teresy 8 Street, 91-348 Lodz, Poland.ORCID 0000-0002-3946-3964
Katarzyna PłoszkaDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Mazowiecka 15, 92-215 Lodz, Poland.ORCID 0000-0002-9573-2719
Damian KołatDepartment of Experimental Surgery, Faculty of Medicine, Medical University of Lodz, 90-136 Lodz, Poland.ORCID 0000-0002-1086-3796
Sylwia PaszekDepartment of General Genetics, Faculty of Medicine, Collegium Medicum, University of Rzeszow, 35-310 Rzeszow, Poland.ORCID 0000-0002-7865-2661
Izabela ZawlikDepartment of General Genetics, Faculty of Medicine, Collegium Medicum, University of Rzeszow, 35-310 Rzeszow, Poland.ORCID 0000-0001-7992-9100
Elżbieta PłuciennikDepartment of Functional Genomics, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland.ORCID 0000-0002-6682-0402
Natalia PotockaLaboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, Collegium Medicum, University of Rzeszow, 35-959 Rzeszow, Poland.ORCID 0000-0002-5505-3922
Wojciech FendlerDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Mazowiecka 15, 92-215 Lodz, Poland.
Paweł KurzawaDepartment of Oncological Pathology, University Clinical Hospital in Poznan, Poznan University of Medical Sciences, 60-514 Poznań, Poland.
Paweł BigosDepartment of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland.
Łukasz UrbańskiDepartment of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland.
Paulina Gibowska-MaruniakDepartment of Surgical Oncology, Institute of Oncology, Poznan University of Medical Sciences Szamarzewskiego 84, 60-569 Poznan, Poland.ORCID 0009-0003-5656-5879
Thomas WowMedical Practice Thomas Wow, 53 Malwowa Street, 60-175 Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the prognostic and predictive properties of four specific genes in triple-negative breast cancer (TNBC). We focused on

Indexed as

Adaptor Proteins, Signal TransducingAdiponectinDNA MethylationGATA4 Transcription FactorTranscription FactorsTriple Negative Breast NeoplasmsAdultAgedBiomarkers, TumorEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticHumansMiddle AgedPrognosisYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingAdiponectinADIPOQ protein, humanBiomarkers, TumorGATA4 protein, humanGATA4 Transcription FactorTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsADIPOQGAS5GATA4TNBCYAP1

Identifiers

PMID41226688
PMCPMC12609348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.